Strain Profile
Save
Bifidobacterium breve B632
◔
Human-origin
Where this strain was first isolated, curated from the literature and culture-collection catalogs. It describes provenance only — not suitability, and not benefit.
How we classify this →
Sequenced
Whether a public genome assembly is linked for this strain. Without one the genome screens cannot run. It is not a verdict on the organism.
How we classify this →
Public genome assembly available
Bifidobacterium breve B632 has been studied primarily in pediatric populations, often in combination with the related strain BR03, across several randomized controlled trials. Clinical research has examined this strain in relation to gut colonization in infants, and trial evidence has examined infantile colic in bottle-fed newborns as a research topic. Studies in children and adolescents with obesity have also examined insulin sensitivity and weight-related measures, and separate trials have examined gastrointestinal symptoms in children with celiac disease. Most studies involve pediatric subjects and combinations with other strains, so B632-specific research in adult populations remains limited. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 16 body-system-tagged papers that concern each system. Research coverage, not measured effect.
Symptoms in the research A tag means the paper's text names the symptom or condition — research coverage, not evidence of benefit. How we classify this →
Share of this strain's 7 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.
+1 more symptoms
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
19 papers reference this strain in the probiotic database.
Match confidence
How strongly this paper was matched to this strain when the corpus was linked. It orders the list — it says nothing about the study's quality or its findings.
How we classify this →
2026
RCT
2025
IN_VITRO
2022
RCT
2020
RCT
2018
RCT
2016
RCT
2015
RCT
2014
IN_VITRO
2014
OBSERVATIONAL
2026
OBSERVATIONAL
2025
REVIEW
2025
IN_VITRO
2021
RCT
2016
RCT
2015
REVIEW
2012
IN_VITRO
2023
IN_VITRO
2021
IN_VITRO
2021
OTHER
Browse all 19 papers →
The beneficial effect of Bifidobacterium breve Br03 and Bifidobacterium breve B632 mixture in acute infectious diarrhea in children
· Probiotics and Antimicrobial Proteins
Dose-Dependent Anti-Inflammatory Effects of Live and Heat-Treated Ligilactobacillus salivarius and Bifidobacterium breve via NF-κB and COX-2 Modulation in an In Vitro Model of Airway Inflammation
· Nutrients
The Probiotics in Pediatric Asthma Management (PROPAM) Study in the Primary Care Setting: A Randomized, Controlled, Double-Blind Trial with Ligilactobacillus salivarius LS01 (DSM 22775) and Bifidobacterium breve B632 (DSM 24706)
· Journal of Immunology Research
Supplementation with Bifidobacterium breve BR03 and Bifidobacterium breve B632 favoured weight loss and improved insulin metabolism in children and adolescents with obesity in the BIFI-OBESE cross-over, randomized placebo-controlled trial
· Endocrine Abstracts
Clinical intervention using Bifidobacterium strains in celiac disease children reveals novel microbial modulators of TNF-α and short-chain fatty acids
· Clinical Nutrition
The Association of Bifidobacterium breve BR03 and B632 is Effective to Prevent Colics in Bottle-fed Infants
· Journal of Clinical Gastroenterology
Administration of Bifidobacterium breve Decreases the Production of TNF-α in Children with Celiac Disease
· Digestive Diseases and Sciences
The Probiotic Bifidobacterium breve B632 Inhibited the Growth of Enterobacteriaceae within Colicky Infant Microbiota Cultures
· BioMed Research International
Capability of the Two Microorganisms Bifidobacterium breve B632 and Bifidobacterium breve BR03 to Colonize the Intestinal Microbiota of Children
· Journal of Clinical Gastroenterology
Parental Perception and Experience in Infants with Colic Symptoms Receiving Probiotic Supplementation
· Pediatric Practice and Research
Current Therapeutic Approaches in Infantile Colic: A Comprehensive Review
· Turkish Archives of Pediatrics
The role of probiotics in modulating pulmonary epithelial inflammation
·
Supplementation with Bifidobacterium breve BR03 and B632 strains improved insulin sensitivity in children and adolescents with obesity in a cross-over, randomized double-blind placebo-controlled trial
· Clinical Nutrition
Can Probiotics Reduce Diarrhea and Infant Mortality in Africa?
· Journal of Clinical Gastroenterology
The role of bifidobacteria in newborn health and the intestinal microbial balance
· AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna)
Assessment of the In Vitro Inhibitory Activity of Specific Probiotic Bacteria Against Different Escherichia coli Strains
· Journal of Clinical Gastroenterology
Millet Fermented by Different Combinations of Yeasts and Lactobacilli: Effects on Phenolic Composition, Starch, Mineral Content and Prebiotic Activity
· Foods
Design of a New Fermented Beverage from Medicinal Plants and Organic Sugarcane Molasses via Lactic Fermentation
· Applied Sciences
Expression in situ of the recombinant human erythropoetin and recombinant insulin.
· International Journal of Endocrinology Diabetes and Metabolism
Discussion
Be the first to comment.
Sign in to join the discussion.
No comments yet.
Citations
Selected papers that name this strain.
-
[1]
PMID 41879960 →The beneficial effect of Bifidobacterium breve Br03 and Bifidobacterium breve B632 mixture in acute infectious diarrhea in children· Probiotics and Antimicrobial Proteins · 2026
-
[2]
Source →The Probiotics in Pediatric Asthma Management (PROPAM) Study in the Primary Care Setting: A Randomized, Controlled, Double-Blind Trial with Ligilactobacillus salivarius LS01 (DSM 22775) and Bifidobacterium breve B632 (DSM 24706)· Journal of Immunology Research · 2022
-
[3]
PMID 29960810 →Clinical intervention using Bifidobacterium strains in celiac disease children reveals novel microbial modulators of TNF-α and short-chain fatty acids· Clinical Nutrition · 2018
-
[4]
PMID 27741166 →The Association of Bifidobacterium breve BR03 and B632 is Effective to Prevent Colics in Bottle-fed Infants· Journal of Clinical Gastroenterology · 2016
-
[5]
PMID 26134988 →Administration of Bifidobacterium breve Decreases the Production of TNF-α in Children with Celiac Disease· Digestive Diseases and Sciences · 2015